2022 Q1 Form 10-Q Financial Statement
#000156459022019885 Filed on May 12, 2022
Income Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
Revenue | $1.435M | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | $9.546M | $8.370M |
YoY Change | 14.05% | 72.58% |
% of Gross Profit | ||
Research & Development | $40.75M | $29.10M |
YoY Change | 40.03% | 24.28% |
% of Gross Profit | ||
Depreciation & Amortization | $1.207M | $1.070M |
YoY Change | 12.8% | 154.76% |
% of Gross Profit | ||
Operating Expenses | $50.30M | $37.46M |
YoY Change | 34.25% | 60.01% |
Operating Profit | -$56.96M | -$37.46M |
YoY Change | 52.04% | 32.53% |
Interest Expense | -$1.077M | $838.0K |
YoY Change | -228.52% | -8.32% |
% of Operating Profit | ||
Other Income/Expense, Net | -$19.00K | -$12.00K |
YoY Change | 58.33% | -103.02% |
Pretax Income | -$58.06M | -$38.31M |
YoY Change | 51.53% | 33.11% |
Income Tax | $0.00 | $0.00 |
% Of Pretax Income | ||
Net Earnings | -$58.06M | -$38.31M |
YoY Change | 51.53% | 33.11% |
Net Earnings / Revenue | -4045.78% | |
Basic Earnings Per Share | -$0.93 | |
Diluted Earnings Per Share | -$928.1K | -$618.1K |
COMMON SHARES | ||
Basic Shares Outstanding | 62.56M | 62.11M |
Diluted Shares Outstanding | 62.56M |
Balance Sheet
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $183.5M | $270.0M |
YoY Change | -32.04% | 161.12% |
Cash & Equivalents | $183.5M | $169.8M |
Short-Term Investments | $100.2M | |
Other Short-Term Assets | $7.021M | $4.000M |
YoY Change | 75.53% | -23.08% |
Inventory | ||
Prepaid Expenses | ||
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $190.5M | $274.0M |
YoY Change | -30.47% | 152.3% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | $22.10M | $50.20M |
YoY Change | -55.97% | 30.39% |
Goodwill | $4.228M | |
YoY Change | ||
Intangibles | $1.320M | |
YoY Change | ||
Long-Term Investments | ||
YoY Change | ||
Other Assets | $1.046M | $3.600M |
YoY Change | -70.94% | -2.7% |
Total Long-Term Assets | $57.64M | $59.30M |
YoY Change | -2.8% | 24.32% |
TOTAL ASSETS | ||
Total Short-Term Assets | $190.5M | $274.0M |
Total Long-Term Assets | $57.64M | $59.30M |
Total Assets | $248.2M | $333.3M |
YoY Change | -25.55% | 113.24% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | $3.589M | $2.500M |
YoY Change | 43.56% | -67.53% |
Accrued Expenses | $32.91M | $20.40M |
YoY Change | 61.34% | -5.99% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Long-Term Debt Due | $3.000M | |
YoY Change | -50.0% | |
Total Short-Term Liabilities | $43.92M | $27.80M |
YoY Change | 57.98% | -30.33% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $57.97M | $26.20M |
YoY Change | 121.25% | 12.93% |
Other Long-Term Liabilities | $42.51M | $51.80M |
YoY Change | -17.93% | 9.28% |
Total Long-Term Liabilities | $100.5M | $78.00M |
YoY Change | 28.82% | 10.48% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $43.92M | $27.80M |
Total Long-Term Liabilities | $100.5M | $78.00M |
Total Liabilities | $144.5M | $105.9M |
YoY Change | 36.4% | -4.16% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$464.9M | |
YoY Change | ||
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | $103.7M | $227.5M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $248.2M | $333.3M |
YoY Change | -25.55% | 113.24% |
Cashflow Statement
Concept | 2022 Q1 | 2021 Q1 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | -$58.06M | -$38.31M |
YoY Change | 51.53% | 33.11% |
Depreciation, Depletion And Amortization | $1.207M | $1.070M |
YoY Change | 12.8% | 154.76% |
Cash From Operating Activities | -$51.30M | -$39.06M |
YoY Change | 31.35% | 70.66% |
INVESTING ACTIVITIES | ||
Capital Expenditures | $743.0K | $475.0K |
YoY Change | 56.42% | -86.49% |
Acquisitions | ||
YoY Change | ||
Other Investing Activities | $0.00 | $125.0M |
YoY Change | -100.0% | -5181.3% |
Cash From Investing Activities | -$743.0K | $124.5M |
YoY Change | -100.6% | -2184.8% |
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 29.23M | 360.0K |
YoY Change | 8019.72% | -91.72% |
NET CHANGE | ||
Cash From Operating Activities | -51.30M | -39.06M |
Cash From Investing Activities | -743.0K | 124.5M |
Cash From Financing Activities | 29.23M | 360.0K |
Net Change In Cash | -22.84M | 85.83M |
YoY Change | -126.61% | -450.15% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$51.30M | -$39.06M |
Capital Expenditures | $743.0K | $475.0K |
Free Cash Flow | -$52.04M | -$39.53M |
YoY Change | 31.65% | 49.73% |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2022Q1 | us-gaap |
Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
|
0.089 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P8Y9M7D | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P8Y9M7D | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
|
true | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P7Y7M20D | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.013 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
|
0.005 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.019 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
|
0.007 | |
CY2021Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
|
P6Y | |
CY2022Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
7021000 | |
CY2022Q1 | us-gaap |
Assets Current
AssetsCurrent
|
190510000 | |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
22101000 | |
CY2022Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
28947000 | |
CY2022Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1320000 | |
CY2022Q1 | us-gaap |
Goodwill
Goodwill
|
4228000 | |
CY2022Q1 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
1046000 | |
CY2022Q1 | us-gaap |
Assets
Assets
|
248152000 | |
CY2022Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
3589000 | |
CY2022Q1 | pstx |
Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
|
29584000 | |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
7386000 | |
CY2022Q1 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
3359000 | |
CY2021Q4 | us-gaap |
Deferred Revenue Current
DeferredRevenueCurrent
|
4497000 | |
CY2022Q1 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
8968000 | |
CY2021Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
9265000 | |
CY2021Q4 | us-gaap |
Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
|
55000 | |
CY2022Q1 | us-gaap |
Revenues
Revenues
|
1435000 | |
CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-37464000 | |
CY2021Q1 | us-gaap |
Interest Expense
InterestExpense
|
838000 | |
CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-12000 | |
CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
-38314000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
124525000 | |
CY2022Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
681000 | |
CY2021Q1 | us-gaap |
Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
|
360000 | |
CY2022Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
1450000 | |
CY2022Q1 | us-gaap |
Proceeds From Short Term Debt
ProceedsFromShortTermDebt
|
30000000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-38314000 | |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
156211000 | |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
103702000 | |
CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
261968000 | |
CY2021Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
|
360000 | |
CY2021Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
3462000 | |
CY2021Q1 | us-gaap |
Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
|
10000 | |
CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-38314000 | |
CY2021Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
227486000 | |
CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-58057000 | |
CY2021Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-38314000 | |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1207000 | |
CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1072000 | |
CY2022Q1 | pstx |
Deferred Revenue In Operating Activities
DeferredRevenueInOperatingActivities
|
1435000 | |
CY2022Q1 | us-gaap |
Loss On Contract Termination
LossOnContractTermination
|
8067000 | |
CY2021Q1 | us-gaap |
Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
|
-4000 | |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
4867000 | |
CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3462000 | |
CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-173000 | |
CY2021Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
-168000 | |
CY2021Q1 | pstx |
Accretion Of Investment Discount Net
AccretionOfInvestmentDiscountNet
|
-46000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
667000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-793000 | |
CY2022Q1 | pstx |
Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
|
1032000 | |
CY2021Q1 | pstx |
Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
|
947000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
|
-616000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-5391000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
1720000 | |
CY2022Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-703000 | |
CY2021Q1 | us-gaap |
Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
|
-8495000 | |
CY2022Q1 | pstx |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-1033000 | |
CY2021Q1 | pstx |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-459000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-51324000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-39056000 | |
CY2022Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
743000 | |
CY2021Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
475000 | |
CY2021Q1 | us-gaap |
Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
|
125000000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-743000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
29231000 | |
CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
360000 | |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-22836000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
85829000 | |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
206325000 | |
CY2020Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
83966000 | |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
183489000 | |
CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
169795000 | |
CY2022Q1 | pstx |
Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities
PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
|
516000 | |
CY2021Q1 | pstx |
Purchases Of Property And Equipment Included In Accounts Payable And Accrued Liabilities
PurchasesOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedLiabilities
|
502000 | |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
718000 | |
CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
671000 | |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-58100000 | |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-51300000 | |
CY2022Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-464900000 | |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
183500000 | |
CY2022Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. On an ongoing basis, the Company evaluates its estimates, which include, but are not limited to, estimates related to revenue, accrued expenses, research and development expenses, stock-based compensation expense and deferred tax valuation allowances. The Company bases its estimates on historical experience and other market-specific or relevant assumptions that it believes to be reasonable under the circumstances. Actual results may differ from those estimates or assumptions. </p> | |
CY2022Q1 | pstx |
Number Of Reportable Segment
NumberOfReportableSegment
|
1 | |
CY2022Q1 | pstx |
Number Of Customer
NumberOfCustomer
|
1 | |
CY2022Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
32445000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
31187000 | |
CY2022Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
10344000 | |
CY2021Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
9137000 | |
CY2022Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
22101000 | |
CY2021Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
22050000 | |
CY2022Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1200000 | |
CY2021Q1 | us-gaap |
Depreciation And Amortization
DepreciationAndAmortization
|
1100000 | |
CY2022Q1 | pstx |
Accrued Contract Research Services Current
AccruedContractResearchServicesCurrent
|
14898000 | |
CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
1326838000 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
9.85 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
9899707 | |
CY2021Q4 | pstx |
Accrued Contract Research Services Current
AccruedContractResearchServicesCurrent
|
12292000 | |
CY2022Q1 | pstx |
Accrued Loss On Contract Termination
AccruedLossOnContractTermination
|
6250000 | |
CY2022Q1 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
4379000 | |
CY2022Q1 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
4057000 | |
CY2022Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
29584000 | |
CY2022Q1 | us-gaap |
Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
|
166128000 | |
CY2022Q1 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
166128000 | |
CY2021Q4 | us-gaap |
Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
|
176102000 | |
CY2022Q1 | us-gaap |
Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
|
2000000.0 | |
CY2022Q1 | pstx |
Debt Instrument Final Payment Fee Accrued
DebtInstrumentFinalPaymentFeeAccrued
|
1700000 | |
CY2022Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
300000 | |
CY2022Q1 | us-gaap |
Common Stock Voting Rights
CommonStockVotingRights
|
Each share of common stock is entitled to one vote. | |
CY2022Q1 | pstx |
Common Stock Dividends Declared
CommonStockDividendsDeclared
|
0 | |
CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
9.57 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
3083132 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
3.88 | |
CY2022Q1 | us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
23303 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.81 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
140663 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
|
9.97 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
12818873 | |
CY2022Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
2300000 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
8.21 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
3674177000 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
12818873 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
8.21 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
|
3674177000 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
3529827 | |
CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
34000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
2400000 | |
CY2022Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
100000 | |
CY2021Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
1600000 | |
CY2022Q1 | us-gaap |
Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
|
600000 | |
CY2022Q1 | us-gaap |
Operating Lease Payments
OperatingLeasePayments
|
1400000 | |
CY2022Q1 | us-gaap |
Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
|
P6Y9M18D | |
CY2021Q1 | us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
400000 | |
CY2022Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
46200000 | |
CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
0.82 | |
CY2022Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
4867000 | |
CY2021Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3462000 | |
CY2022Q1 | us-gaap |
Area Of Land
AreaOfLand
|
110000 | |
CY2022Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
4400000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
|
Certain of the Company’s manufacturing, laboratory and office space lease agreements include two options to extend the term for a period of 5 years each. | |
CY2022Q1 | pstx |
Lessee Operating Lease Number Of Options To Extend Term
LesseeOperatingLeaseNumberOfOptionsToExtendTerm
|
2 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
|
P5Y | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
|
6374000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
|
5107000 | |
CY2022Q1 | pstx |
Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
|
16260000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
|
46914000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
|
11680000 | |
CY2022Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
35234000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
|
6188000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
|
5928000 | |
CY2022Q1 | us-gaap |
Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
|
7057000 | |
CY2022Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
7386000 | |
CY2022Q1 | us-gaap |
Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
|
27848000 | |
CY2022Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15081026 | |
CY2021Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
9015702 |